Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank75
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

Percentile
P75
Within normal range
vs 2Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$1.99M-6.5%
2024$2.13M+25.0%
2023$1.71M-
2022$0.00-
2021$0.00-